Hoxton Ventures Closes Second Venture Capital Fund
Summary
The new early stage fund will build on the firm’s record of finding and investing in “unicorns,” which includes seed investments in Babylon Health, Darktrace and Deliveroo. The firm’s strategy is to continue to find European companies that can scale globally into large, category-defining leaders in newly forming industries. Led by Hussein Kanji, Rob Kniaz, and Rob Ludwig, Hoxton typically invests between $500,000 and $5 million into pre-seed, seed and Series A stage companies, and follows its capital through the life of the company. The fund expects most of its investments will target the U.S. market, either by opening offices in the U.S. or building a sales presence in the U.S. The new fund began investing in early 2019 and has made 20 investments across a range of sectors, including seed investments in FabricNano, a next generation enzyme business, Fy!, a homewares marketplace, Kbox Global, a cloud kitchen business, Kheiron Medical, an artificial intelligence radiology startup, and Preply, an online education company.